GIA announces the release of a comprehensive global report on Nuclear Medicine Imaging Equipment market. Global market for Nuclear Medicine Imaging Equipment is forecast to reach US$2.5 billion by 2020, buoyed by advances in SPECT systems and PET scanners as well as the increased popularity of hybrid imaging systems such as PET/CT and SPECT/CT.
San Jose, California (PRWEB) August 05, 2014
Follow us on LinkedIn – Rising incidence of diseases, such as cancer, cardiovascular disease (CVD) and CNS conditions, such as Alzheimer’s disease (AD) is a major factor promoting demand for nuclear medicine imaging equipment. Aging population, a significant risk group, also represents a vital demographic driver. The market for nuclear medicine is influenced by advances in cancer therapies and improved understanding of disease pathologies, down to the molecular level. PET and SPECT systems dominate the field of nuclear medicine equipment. Technological advancements, such as the introduction of Time of Flight (TOF) as well as the increasing popularity of hybrid imaging systems, such as SPECT/MRI systems play a major role in determining demand. Additional impetus for nuclear medicine imaging equipment is expected to come from advances in diagnostic imaging software, such as iterative reconstruction, resolution recovery, and noise compensation; as well as hardware improvements, such as cardio-centric collimators and solid-state detectors, among others.
The emergence of sophisticated digital technologies and their use in the world of diagnostic imaging is presenting new opportunities for market participants. Despite disparity in healthcare spending, both the developed and developing markets are forecast to be driven by trends, such as rising incidence of chronic diseases, growing geriatric population, and robust development of the life sciences sector. Despite the opportunities for growth, the market is expected to confront challenges such as volatile supply chain of Tc-99 the most common diagnostic radioisotope; unfounded fear over radiation exposure; limitations on reimbursement, and inadequate production of radioisotopes in developing countries and logistical difficulties associated with their imports. However, growing interest in the use of PET Imaging in drug-development as well as expanding application of the imaging modality in cardiology and neurology supported by the introduction of novel and advanced radiotracers are expected to benefit market growth.
As stated by the new market research report on Nuclear Medicine Imaging Equipment, the United States represents the largest market worldwide, followed by Europe. Growing awareness of various diagnostic procedures, as well as increased emphasis on early detection for improved therapeutic results, are major factors promoting demand for nuclear medicine in the United States. In addition, rising preference for non-invasive and minimally invasive procedures for diagnosis and treatment is also helping boost sales. Asia-Pacific represents the fastest growing market with a compounded annual growth rate (CAGR) of approximately 7.5% over the analysis period. Rising incidence of cancer cases as well as the surge in cardiac conditions bode well for growth in the region. The market is also expected to receive a boost from rising income levels, growing affluence, and the strong focus on early diagnosis for improved treatment results.
Major players covered in the report include Digirad Corporation, GE Healthcare, Mediso Medical Imaging Systems, Philips Healthcare, Positron Corporation, and Siemens Healthcare among others.
The research report titled “Nuclear Medicine Imaging Equipment: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the nuclear medicine market, key market trends, growth drivers, product overview, mergers and acquisitions, and other strategic corporate initiatives of companies worldwide. The report provides market estimates/projections in value terms for all major geographic markets, including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Product segments analyzed include SPECT systems (including SPECT/CT systems) and PET Scanners (including PET/CT scanners) for the aforementioned geographic regions.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Nuclear_Medicine_Imaging_Equipment_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
### Reported by PRWeb 11 minutes ago.
San Jose, California (PRWEB) August 05, 2014
Follow us on LinkedIn – Rising incidence of diseases, such as cancer, cardiovascular disease (CVD) and CNS conditions, such as Alzheimer’s disease (AD) is a major factor promoting demand for nuclear medicine imaging equipment. Aging population, a significant risk group, also represents a vital demographic driver. The market for nuclear medicine is influenced by advances in cancer therapies and improved understanding of disease pathologies, down to the molecular level. PET and SPECT systems dominate the field of nuclear medicine equipment. Technological advancements, such as the introduction of Time of Flight (TOF) as well as the increasing popularity of hybrid imaging systems, such as SPECT/MRI systems play a major role in determining demand. Additional impetus for nuclear medicine imaging equipment is expected to come from advances in diagnostic imaging software, such as iterative reconstruction, resolution recovery, and noise compensation; as well as hardware improvements, such as cardio-centric collimators and solid-state detectors, among others.
The emergence of sophisticated digital technologies and their use in the world of diagnostic imaging is presenting new opportunities for market participants. Despite disparity in healthcare spending, both the developed and developing markets are forecast to be driven by trends, such as rising incidence of chronic diseases, growing geriatric population, and robust development of the life sciences sector. Despite the opportunities for growth, the market is expected to confront challenges such as volatile supply chain of Tc-99 the most common diagnostic radioisotope; unfounded fear over radiation exposure; limitations on reimbursement, and inadequate production of radioisotopes in developing countries and logistical difficulties associated with their imports. However, growing interest in the use of PET Imaging in drug-development as well as expanding application of the imaging modality in cardiology and neurology supported by the introduction of novel and advanced radiotracers are expected to benefit market growth.
As stated by the new market research report on Nuclear Medicine Imaging Equipment, the United States represents the largest market worldwide, followed by Europe. Growing awareness of various diagnostic procedures, as well as increased emphasis on early detection for improved therapeutic results, are major factors promoting demand for nuclear medicine in the United States. In addition, rising preference for non-invasive and minimally invasive procedures for diagnosis and treatment is also helping boost sales. Asia-Pacific represents the fastest growing market with a compounded annual growth rate (CAGR) of approximately 7.5% over the analysis period. Rising incidence of cancer cases as well as the surge in cardiac conditions bode well for growth in the region. The market is also expected to receive a boost from rising income levels, growing affluence, and the strong focus on early diagnosis for improved treatment results.
Major players covered in the report include Digirad Corporation, GE Healthcare, Mediso Medical Imaging Systems, Philips Healthcare, Positron Corporation, and Siemens Healthcare among others.
The research report titled “Nuclear Medicine Imaging Equipment: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the nuclear medicine market, key market trends, growth drivers, product overview, mergers and acquisitions, and other strategic corporate initiatives of companies worldwide. The report provides market estimates/projections in value terms for all major geographic markets, including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Product segments analyzed include SPECT systems (including SPECT/CT systems) and PET Scanners (including PET/CT scanners) for the aforementioned geographic regions.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Nuclear_Medicine_Imaging_Equipment_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
### Reported by PRWeb 11 minutes ago.